pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 396 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
SPL-84
Cystic Fibrosis
SpliSense Ltd
0 catalysts
Phase 2
STMC-103H
Allergies
Siolta Therapeutics Inc
0 catalysts
Marketed
Sclerosol
Sclerosol (talc [USP])
Malignant Pleural Effusion
Sciarra Laboratories Inc (Inactive)
0 catalysts
Preclinical
Small Molecule to Inhibit MAPK13 and MAPK14 for Breast Cancer and Respiratory Disease
← prev
page 8 of 14
next →
131
Pain89
Neurology1
Asthma
NuPeak Therapeutics Inc
0 catalysts
Marketed
Spiriva
Spiriva Handihaler (tiotropium bromide)
Bronchospasm
Boehringer Ingelheim Corp
0 catalysts
Phase 2
TLP-02
Metablok
Acute Respiratory Distress Syndrome
Arch Biopartners Inc
0 catalysts
Marketed
Trelegy Ellipta
Trelegy Ellipta ((fluticasone furoate + umeclidinium bromide + vilanterol trifenatate))
Asthma
GlaxoSmithKline LLC
0 catalysts
Phase 2
VAX-24
Streptococcal Pneumonia
$PCVXVaxcyte, Inc.
0 catalysts
Phase 3
VAX-31
Streptococcal Pneumonia
$PCVXVaxcyte, Inc.
0 catalysts
Marketed
Vaxneuvance
Streptococcal Pneumonia
$MRKMerck & Co., Inc.
0 catalysts
Marketed
Zurnai
Zurnai (nalmefene)
Acute Opioid Overdosage
Purdue Pharma LP
0 catalysts
Marketed
acetazolamide sodium
Acetazolamide Sodium (acetazolamide sodium)
Closed-Angle Glaucoma
X-GEN Pharmaceuticals DJB Inc
0 catalysts
Marketed
aclidinium bromide
Tudorza Pressair (aclidinium bromide)
Bronchospasm
Covis Group Sarl
0 catalysts
Phase 3
admilparant
Idiopathic Pulmonary Fibrosis
Bristol-Myers Squibb Co
0 catalysts
Marketed
albumin (human)
Human Albumin (albumin (human))
Hypovolemia (Hypovolaemia)
Octapharma USA Inc
0 catalysts
Phase 2
alpha-1 proteinase inhibitor (human)
Prolastin (alpha-1 proteinase inhibitor (human))
Lung Transplant Rejection
Neutrophil elastase
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Marketed
ampicillin
Ampicillin Trihydrate (ampicillin)
Bacterial Pneumonia
Sandoz Inc
0 catalysts
Marketed
arformoterol tartrate
Arformoterol Tartrate (arformoterol tartrate)
Chronic Bronchitis
The Ritedose Corp
0 catalysts
Marketed
armodafinil
Armodafinil (armodafinil)
Obstructive Sleep Apnea
CorePharma LLC
0 catalysts
Marketed
ascorbic acid
Ascor (ascorbic acid [INN])
Bronchiolitis Obliterans
Renovion Inc
0 catalysts
Phase 3
astegolimab
Chronic Obstructive Pulmonary Disease (COPD)
IL-33 receptor (ST2)
F. Hoffmann-La Roche Ltd
0 catalysts
Phase 2
aviptadil
Acute Respiratory Distress Syndrome
Adrenergic receptor alpha
$RLFTYMindMaze Therapeutics Holding SA
0 catalysts
Marketed
azelastine hydrochloride
Azelastine Hydrochloride Wallace (azelastine hydrochloride)
Allergic Rhinitis
Wallace Pharmaceuticals Inc
0 catalysts
Marketed
azithromycin
Azasite (azithromycin)
Bacterial Conjunctivitis
Thea Pharma Inc
0 catalysts
Marketed
aztreonam lysine
Cayston (aztreonam lysine)
Cystic Fibrosis
$GILDGILEAD SCIENCES, INC.
0 catalysts
Marketed
bacitracin
Bacitracin (bacitracin [INN])
Bacterial Conjunctivitis
Padagis LLC
0 catalysts
Phase 2
bedoradrine sulfate
Asthma
Beta-2 adrenergic receptor
$MNOVMEDICINOVA INC
0 catalysts
pre_registration
benralizumab
Fasenra (benralizumab)
Hypereosinophilic Syndrome
Interleukin-5 receptor subunit alpha
$AZNASTRAZENECA PLC
0 catalysts
Marketed
benzylpenicillin
Penicillin G Potassium (benzylpenicillin [INN])
Actinomycosis
Avenacy Inc
0 catalysts
Marketed
beractant
Survanta (beractant)
Neonatal Respiratory Distress Syndrome
$ABBVAbbVie Inc.
0 catalysts